Key Market Indicator:
F&G: 55
25.562,04 NASDAQ · 49.131,99 DOW · 6.906,59 S&P · 4.980,35 Gold · 65,10 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
03.05.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading statement Q1 2024
Article
News Preview
Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023
Article
News Preview
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Financial Results for the First Quarter of 2024
Article
News Preview
May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
02.05.2024
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
Article
News Preview
Company to host public L(earnings) Call on May 9 at 5:00 pm ET Company to host public L(earnings) Call on May 9 at 5:00 pm ET...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
02.05.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon veranstaltet Telefonkonferenz zu den Ergebnissen des ersten Quartals 2024
Article
News Preview
Pressemitteilung // 02. Mai 2024 Formycon veranstaltet Telefonkonferenz zu den Ergebnissen des ersten Quartals 2024 Planegg-Martinsried – Die Formycon AG (FWB: FYB, 'Formycon') hat heute Details zur Telefonkonferenz zur Veröffentlichung der Zahlen des ersten Quartals 2024 am 08. Mai 2024 bekannt gegeben. Der Vorstand wird dabei die Entwicklung de......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.05.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon hosts conference call on the results of the first quarter 2024
Article
News Preview
Press Release // May 02, 2024 Formycon hosts conference call on the results of the first quarter 2024 Planegg-Martinsried – Formycon AG (FWB: FYB, 'Formycon') today announced details of the conference call to release the results of the first quarter 2024 on May 08, 2024. The management board will discuss the company's developments and key financi......
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2024
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
Article
News Preview
Louvain-La-Neuve, Belgium, 2 May 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International, for the installation of a Prot...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2024
ISIN: DK0010272632
GN Store Nord A/S
GN
LISTED
CPH
Interim Report Q1 2024: GN Store Nord delivered organic revenue growth of 5% reaching an EBITA margin of 12.5%
Article
News Preview
Highlights...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.05.2024
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion to Participate in Upcoming Investor Conferences
Article
News Preview
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations
Article
News Preview
SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations Tobias Erfurth übernimmt Leitung des Investor Relations-Teams ab Mitte August 2024 Er verfügt über mehr als 20 Jahre Erfahrung im Finanz- und Kapitalmarktsektor sowie im Bereich Investor Relations SCHOTT Pharma, ein Pionier für pharmazeutische Aufbewahrungs- und Verabreichungssyst......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations
Article
News Preview
SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations Tobias Erfurth übernimmt Leitung des Investor Relations-Teams ab Mitte August 2024 Er verfügt über mehr als 20 Jahre Erfahrung im Finanz- und Kapitalmarktsektor sowie im Bereich Investor Relations SCHOTT Pharma, ein Pionier für pharmazeutische Aufbewahrungs- und Verabreichungssyst......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
Article
News Preview
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations Tobias Erfurth will lead Investor Relations Team starting in August 2024. He brings more than 20 years of experience in finance, capital markets and investor relations. SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today announced the appoint......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie
Article
News Preview
DIE BAYER UND EVOTEC ERWEITERN DEN FOKUS IHRER ZUSAMMENARBEIT AUF HERZ-KREISLAUF-ERKRANKUNGEN STRATEGISCHE ALLIANZ NUTZT DIE MODELLIERUNG VON KRANKHEITEN DURCH MENSCHLICHE INDUZIERTE PLURIPOTENTE STAMMZELLEN ZUR IDENTIFIZIERUNG NEUER WIRKSTOFFZIELE GEMEINSAME ANSTRENGUNGEN ZIELEN AUF DIE ENTWICKLUNG INNOVATIVER THERAPIEN IN DER PRÄZISIONSKARDIOLO......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie
Article
News Preview
DIE BAYER UND EVOTEC ERWEITERN DEN FOKUS IHRER ZUSAMMENARBEIT AUF HERZ-KREISLAUF-ERKRANKUNGEN STRATEGISCHE ALLIANZ NUTZT DIE MODELLIERUNG VON KRANKHEITEN DURCH MENSCHLICHE INDUZIERTE PLURIPOTENTE STAMMZELLEN ZUR IDENTIFIZIERUNG NEUER WIRKSTOFFZIELE GEMEINSAME ANSTRENGUNGEN ZIELEN AUF DIE ENTWICKLUNG INNOVATIVER THERAPIEN IN DER PRÄZISIONSKARDIOLO......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer and Evotec collaborate to advance precision cardiology
Article
News Preview
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS JOINT EFFORT AIMS TO DEVELOP INNOVATIVE THERAPIES IN PRECISION CARDIOLOGY   Berlin and Hamburg, Germany, 30 April 2024: Bayer and the German-based l......
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2024
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023
Article
News Preview
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced that the company has been granted extension until 31 May 2024 to publish its 2023 annual report and to file such report with SIX Exchange Regulat...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.04.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer partners with RxCap to offer connected adherence solutions
Article
News Preview
Gerresheimer partners with RxCap to offer connected adherence solutions  Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S. Adherence solutions enables pharmacies to offer remote therapeutic monitoring Digital therapy support leads to improved health outcomes Düsseldorf/Berlin, Ohio, USA, April 29, 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.04.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer partners with RxCap to offer connected adherence solutions
Article
News Preview
Gerresheimer partners with RxCap to offer connected adherence solutions  Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S. Adherence solutions enables pharmacies to offer remote therapeutic monitoring Digital therapy support leads to improved health outcomes Düsseldorf/Berlin, Ohio, USA, April 29, 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.04.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen
Article
News Preview
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen Gerresheimer-Tochter Centor erhält exklusive Vertriebsrechte für Apotheken in den USA Adhärenz-Lösungen für therapeutische Fernüberwachung durch Apotheken Digitale Lösungen zur Therapieunterstützung verbessern Behandlungsergebnis Düsseldorf/Berlin, Ohio, USA, 29. April......
Themefolio
Profiler
Peergroup
© Newsfile
25.04.2024
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo Announces Leadership Changes
Article
News Preview
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed as new Chairman of the Board. Incumbent Chairman Mauro Ajani to continue as a Board member. Additiona...
Themefolio
Profiler
Peergroup
© EQS Newswire
25.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon veröffentlicht testierten Jahresabschluss für das Geschäftsjahr 2023 – Rückblick auf ein erfolgreiches operatives Jahr und übertroffene Prognose
Article
News Preview
Pressemitteilung // 25. April 2024 Formycon veröffentlicht testierten Jahresabschluss für das Geschäftsjahr 2023 – Rückblick auf ein erfolgreiches operatives Jahr und übertroffene Prognose Vorläufige Zahlen für 2023 final bestätigt Konzernumsatz steigt im Vergleich zum Vorjahr um 83% auf 77,7 Mio. € Positives Konzern-EBITDA in Höhe von rund 1,5......
Themefolio
Profiler
Peergroup
© EQS Newswire
25.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance
Article
News Preview
Press release // April 25, 2024 Formycon reports audited annual results for the financial year 2023 – Looking back on a successful operative year and exceeded guidance Preliminary results 2023 confirmed Group revenue increases by 83% compared to the previous year to a total of € 77.7 million Positive Group EBITDA of around € 1.5 million and adj......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus
Article
News Preview
FINANZERGEBNIS 2023 ERREICHT IN ALLEN PUNKTEN DIE AKTUALISIERTE PROGNOSE NEUAUSRICHTUNG DER PRIORITÄT AUF PROFITABLES WACHSTUM: ANPASSUNGEN BEI GRÖẞE UND STANDORTEN, UM JÄHRLICHEN EBITDA-BEITRAG VON MEHR ALS 40 MIO. € ZU ERREICHEN EVOTECS BERICHTSSTRUKTUR VERÄNDERT SICH MIT DEM ERSTEN QUARTAL 2024 ZU DEN SEGMENTEN “SHARED R&D” UND “JUST – EVO......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
Article
News Preview
FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST – EVOTEC BIOLOGICS” STARTING Q1 2024 Hamburg, Germany, 24 April 202......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Article
News Preview
Hamburg, Germany, 23 April 2024: The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer (“CEO”), effective 01 July 2024. The election was unanimous and is the result of an extensive selection process that bega......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer
Article
News Preview
Hamburg, 23. April 2024: Der Aufsichtsrat der Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) hat Dr. Christian Wojczewski mit Wirkung zum 1. Juli 2024 zum Chief Executive Officer („CEO“) von Evotec ernannt. Die Wahl erfolgte einstimmig und ist das Ergebnis eines im Januar 2024 begonnen umfassenden Auswahl......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer
Article
News Preview
Hamburg, Deutschland – Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) gibt die Ernennung von Dr. Christian Wojczewski zum Chief Executive Officer („CEO“) von Evotec mit Wirkung zum 1. Juli 2024 bekannt. Dr. Wojczewski ist studierter Chemiker mit über 20 Jahren Erfahrung in u......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Article
News Preview
Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces the appointment of Dr Christian Wojczewski as Chief Executive Officer of the Company, effective 01 July 2024. Dr Wojczewski holds a degree in chemistry and has over 20 years of experience in various man......
Themefolio
Profiler
Peergroup
© PR Newswire
22.04.2024
ISIN: GB00B2425G68
Craneware PLC
CRW
LISTED
AIMX
The Craneware Group Celebrates 25 Years of Success, Highlights Customer Commitment and Innovation as Keys to Longevity
Article
News Preview
DEERFIELD BEACH, Fla., April 22, 2024 /PRNewswire/ -- This month, The Craneware Group, a leader in healthcare financial performance and 340B management, celebrates its 25th anniversary. Since 1999, they've partnered with US healthcare providers, enhancing operational efficiency and financial performance to deliver quality care. With their flagshi...
Themefolio
Profiler
Peergroup
© EQS Newswire
22.04.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
Article
News Preview
1st Quarter 2024: Sales of EUR 67.6 million (previous year: EUR 57.9 million) EBIT before special items of EUR 15.0 million (previous year: EUR 10.7 million) Net income for the year of EUR 8.5 million (previous year: EUR 4.7 million) Forecast FY 2024: Sales of just under 265 million EUR (confirmed) EBIT before special items of around EUR 50 mi......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.04.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
Article
News Preview
1st Quarter 2024: Sales of EUR 67.6 million (previous year: EUR 57.9 million) EBIT before special items of EUR 15.0 million (previous year: EUR 10.7 million) Net income for the year of EUR 8.5 million (previous year: EUR 4.7 million) Forecast FY 2024: Sales of just under 265 million EUR (confirmed) EBIT before special items of around EUR 50 mi......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.04.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler in Q1 mit deutlichem Anstieg bei Umsatz und Ergebnis gegenüber Vorjahr. Jahresprognose 2024 bestätigt.
Article
News Preview
1. Quartal 2024: Umsatz 67,6 Mio. EUR (VJ: 57,9 Mio. EUR) EBIT vor Sondereinflüssen 15,0 Mio. EUR (VJ:10,7 Mio. EUR) Nettogewinn 8,5 Mio. EUR (VJ: 4,7 Mio. EUR) Jahresprognose 2024: Umsatz von knapp 265 Mio. EUR (bestätigt) EBIT vor Sondereinflüssen von rund 50 Mio. EUR (bestätigt) Berlin, 22.04.2024. Die Eckert & Ziegler SE (ISIN DE000565......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024
Article
News Preview
Press Release // April 22, 2024   Formycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024   Munich - Formycon AG (FWB: FYB, 'Formycon') today announced details of the conference call to release the results of the financial year 2......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2023 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2024 bekannt
Article
News Preview
Pressemitteilung // 22. April 2024   Formycon lädt zur Telefonkonferenz zu den Ergebnissen des Geschäftsjahres 2023 ein und gibt Teilnahme an internationalen Investorenkonferenzen im 2. Quartal 2024 bekannt   München – Die Formycon AG (FWB: FYB, „Formycon“) hat heute Details zur Telefonkonferenz zur Veröffentlichung der Ergebnisse des Geschäftsja......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva | Rating: Buy
Article
News Preview
Original-Research: Valneva - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva Unternehmen: Valneva ISIN: FR0004056851 Anlass der Studie: Update Empfehlung: Buy seit: 12.04.2024 Kursziel: €8.60 Kursziel auf Sicht von: 12 months Letzte Ratingänderung: - Analyst: Simon Scholes, CFA First Berlin Equity ......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
Article
News Preview
  COLLABORATION LEVERAGES VARIANT BIO’S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC’S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS TO EVOTEC BASED ON THE OVERALL SUCCESS OF THE PROGRAMM......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und Variant Bio gehen strategische Partnerschaft zur Entdeckung und Entwicklung von Fibrose-Behandlungen ein
Article
News Preview
  DIE KOLLABORATION NUTZT VARIANT BIOS HOCHMODERNE GENOMIK-FORSCHUNGSPLATTFORM UND EVOTECS INTEGRIERTE END-TO-END F&E-PLATTFORM UND EXPERTISE IM KRANKHEITSBEREICH, UM UNGEDECKTEN MEDIZINISCHEN BEDARF IN FIBROTISCHEN INDIKATIONEN ANZUGEHEN DIE KOMMERZIELLEN BEDINGUNGEN UMFASSEN FORSCHUNGSZAHLUNGEN SOWIE MEILENSTEINE UND/ODER UMSATZBETEILIGUNGE......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0007165607
Sartorius AG
SRT
LISTED
XETRA
Ergebnisse des 1. Quartals im Rahmen der Erwartungen; Wiederholgeschäft mit deutlichem Auftragswachstum; Nachfrage aus China weiter schwach; Ausblick für Gesamtjahr bestätigt
Article
News Preview
  Göttingen, 18. April 2024 Sartorius: Ergebnisse des 1. Quartals im Rahmen der Erwartungen; Wiederholgeschäft mit deutlichem Auftragswachstum; Nachfrage aus China weiter schwach; Ausblick für Gesamtjahr bestätigt   Lagerbestandsabbau bei Kunden weiter fortgeschritten; Auftragseingang steigt wechselkursbereinigt um knapp 10 Prozent Umsatzentwickl......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0007165607
Sartorius AG
SRT
LISTED
XETRA
First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
Article
News Preview
  Göttingen, April 18, 2024 Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed   Inventory reduction at customers further advanced; order intake increases by almost 10 percent in constant currencies Sales revenue down by 7.6 ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das Geschäftsjahr 2023 am 24. April 2024
Article
News Preview
  Hamburg, 17. April 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 24. April 2024, ihren Bericht über das Geschäftsjahr 2023. In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wi......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce results for fiscal year 2023 on 24 April 2024
Article
News Preview
Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec heißt Aurélie Dalbiez als Chief People Officer willkommen
Article
News Preview
Hamburg, 17. April 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Ernennung von Aurélie Dalbiez als neue Chief People Officer („CPO“) des Unternehmens mit Wirkung zum 15. Juni 2024 bekannt. Als neues Vorstandsmitglied wird Aurélie eine Fülle von Erfahrungen und Fachwissen im Bereich de......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Article
News Preview
Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer (“CPO”), effective 15 June 2024. Aurélie will be joining Evotec’s Management Board, bringing with her a wealth of experience and experti......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Überzeugende Gesamtbilanz – Formycon berichtet vorläufige Zahlen für das Geschäftsjahr 2023 und übertrifft Prognose
Article
News Preview
Pressemitteilung // 12. April 2024   Überzeugende Gesamtbilanz – Formycon berichtet vorläufige Zahlen für das Geschäftsjahr 2023 und übertrifft Prognose   Konzernumsatz steigt im Vergleich zum Vorjahr um ca. 83 % auf insgesamt 77,7 Mio. € Positives Konzern-EBITDA in Höhe von rund 1,5 Mio. € verzeichnet Neue Finanzkennzahl „Bereinigtes Konzern-......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast
Article
News Preview
Press release // 12 April 2024   Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast   Group revenue increase by 83% compared to the previous year to a total of € 77.7 million Positive Group EBITDA of around € 1.5 million achieved New key financial performance indicator (KPI) "......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon AG veröffentlicht vorläufige Geschäftszahlen für das Geschäftsjahr 2023 und Prognose für das Geschäftsjahr 2024
Article
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014 Formycon AG veröffentlicht vorläufige Geschäftszahlen für das Geschäftsjahr 2023 und Prognose für das Geschäftsjahr 2024 Planegg-Martinsried, Deutschland, 12. April 2024 – Die Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY) ("Gesellschaft") erwartet auf Basis......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year
Article
News Preview
Disclosure of inside information according to Article 17 of the Regulation (EU) No 596/2014 Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year Planegg-Martinsried, Germany, 12. April 2024 – Based on preliminary and unaudited figures for the 2023 financial year, Formycon AG (ISIN: DE000A1......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.04.2024
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva | Rating: Buy
Article
News Preview
Original-Research: Valneva - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Valneva Company Name: Valneva ISIN: FR0004056851 Reason for the research: Update Recommendation: Buy from: 12.04.2024 Target price: €8.60 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes First B......
Themefolio
Profiler
Peergroup
© Newsfile
12.04.2024
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Article
News Preview
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon gibt Markteinführung von FYB201 (Ranibizumab) in Kanada (RanoptoTM) und der Schweiz (Ranivisio®) bekannt
Article
News Preview
Pressemitteilung // 11. April 2024   Formycon gibt Markteinführung von FYB201 (Ranibizumab) in Kanada (RanoptoTM) und der Schweiz (Ranivisio®) bekannt   Kommerzieller Launch erschließt weitere wichtige Märkte in Europa und Nordamerika – FYB201 ist damit in 17 Ländern weltweit verfügbar Lucentis®-Biosimilar FYB201 stellt eine wirksame und kosten......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2024
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®)
Article
News Preview
Press release // April 11, 2024   Formycon announces commercial launch of FYB201 (Ranibizumab) in Canada (RanoptoTM) and Switzerland (Ranivisio®)   Commercial launch opens up additional key markets in Europe and North America, making FYB201 available in a total of 17 countries worldwide Lucentis® biosimilar FYB201 is an effective and cost-effi......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer makes solid start to the financial year 2024
Article
News Preview
Gerresheimer makes solid start to the financial year 2024 Organic growth: Revenues +2.8%, adjusted EBITDA +5.9%  Capacity expansion in the Americas, Europe and Asia progresses according to plan Guidance confirmed Düsseldorf, April 11, 2024 Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2024
ISIN: DE000A0LD6E6
Gerresheimer AG
GXI
LISTED
XETR
Gerresheimer mit solidem Start ins Geschäftsjahr 2024
Article
News Preview
Gerresheimer mit solidem Start ins Geschäftsjahr 2024 Organisches Wachstum: Umsatz +2,8 %, Adjusted EBITDA +5,9 %  Kapazitätsausbau in Amerika, Europa und Asien schreitet wie geplant voran Prognose bestätigt Düsseldorf, 11. April 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für die Pharma-, Biotech- und Kosmet......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.03.2024
ISIN: DE0007165607
Sartorius AG
SRT
LISTED
XETRA
Resolutions of the Annual General Meeting of Sartorius AG
Article
News Preview
Göttingen, March 28, 2024 Resolutions of the Annual General Meeting of Sartorius AG At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 0.74 euros per preference share and 0.73 euro......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.03.2024
ISIN: DE0007165607
Sartorius AG
SRT
LISTED
XETRA
Beschlüsse der Hauptversammlung der Sartorius AG
Article
News Preview
Göttingen, 28. März 2024 Beschlüsse der Hauptversammlung der Sartorius AG Die Aktionärinnen und Aktionäre der Sartorius AG haben bei der heutigen virtuellen Hauptversammlung den Vorschlägen von Aufsichtsrat und Vorstand mit großer Mehrheit zugestimmt. Sie beschlossen unter anderem die Ausschüttung einer Dividende in Höhe von 0,74 Euro je Vorzugsak......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios achieves double-digit growth in 2023 – Positive outlook for 2024
Article
News Preview
Press release Medios achieves double-digit growth in 2023 – Positive outlook for 2024 Berlin, March 27, 2024 - Medios AG ("Medios"), the leading provider of specialty pharma solutions in Germany, once again grew strongly in the 2023 financial year. From January to December 2023, consolidated revenue increased by 10.8% to around €1.8 billion (prev......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.03.2024
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Medios wächst 2023 zweistellig – Positiver Ausblick für 2024
Article
News Preview
Pressemitteilung Medios wächst 2023 zweistellig – Positiver Ausblick für 2024 Berlin, 27. März 2024 – Die Medios AG („Medios“), der führende Anbieter von Specialty Pharma Solutions in Deutschland, ist im Geschäftsjahr 2023 erneut stark gewachsen. Von Januar bis Dezember 2023 stieg der Konzernumsatz um 10,8 % auf rund 1,8 Mrd. € (Vj. 1,6 Mrd. €) u......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.03.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
Article
News Preview
Berlin, March 22, 2024 - Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) generated sales of € 246.1 million in the 2023 financial year. Compared to the previous year, sales increased by € 23.8 million or 11%. EBIT from continuing operations before special items reached € 46.9 million. Net profit for the year amounted to € 26.3 million correspon......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.03.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler nach erfolgreichem Geschäftsjahr 2023 weiterhin auf Wachstumskurs
Article
News Preview
Berlin, den 22.3.2024 – Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erzielte im Geschäftsjahr 2023 einen Umsatz von 246,1 Mio. €. Im Vergleich zum Vorjahr legte der Umsatz um 23,8 Mio. € oder 11% zu. Das EBIT aus fortgeführten Geschäftsbereichen vor Sondereinflüssen betrug 46,9 Mio. €. Der Jahresüberschuss erreichte 26,3 Mio. € und ents......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.03.2024
ISIN: DE0005659700
Eckert & Ziegler SE
EUZ
LISTED
XETR
Eckert & Ziegler nach erfolgreichem Geschäftsjahr 2023 weiterhin auf Wachstumskurs
Article
News Preview
Berlin, den 22.3.2024 – Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erzielte im Geschäftsjahr 2023 einen Umsatz von 246,1 Mio. €. Im Vergleich zum Vorjahr legte der Umsatz um 23,8 Mio. € oder 11% zu. Das EBIT aus fortgeführten Geschäftsbereichen vor Sondereinflüssen betrug 46,9 Mio. €. Der Jahresüberschuss erreichte 26,3 Mio. € und ents......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 23.01.2026, Calendar Week 04, 23rd day of the year, 342 days remaining until EoY.